Cybin's Acquisition Of Small Pharma Approved By Canadian Supreme Court
Portfolio Pulse from Lara Goldstein
Small Pharma Inc. (OTCQB:DMTTF) has received final approval from the Supreme Court of British Columbia for its acquisition by Cybin Inc. (NYSE:CYBN) in an all-share transaction. The deal is expected to close on or about October 23, 2023. After the completion, Small Pharma's shares will be delisted from the TSXV and OTCQB Venture Market.
October 18, 2023 | 6:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cybin Inc. is set to acquire Small Pharma Inc. in an all-share transaction.
The acquisition of Small Pharma by Cybin Inc. could potentially increase Cybin's market share and expand its product portfolio, which could positively impact its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Small Pharma Inc. will be acquired by Cybin Inc. and its shares will be delisted from the TSXV and OTCQB Venture Market.
The delisting of Small Pharma's shares from the TSXV and OTCQB Venture Market post-acquisition could negatively impact its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100